Myeloma: FDA Advisers Greenlight Early CAR-T Myeloma: FDA Advisers Greenlight Early CAR-T

An FDA advisory panel endorsed earlier use of CAR-T therapies to treat multiple myeloma but emphasized the importance of informing patients about potential risks associated with these treatments.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news